                         SEQUENCE LISTING

<110>  STC.UNM
       SANDIA CORPORATION
 
<120>  Porous Nanoparticle-Supported Lipid Bilayers (Protocells) for 
       Targeted Delivery Including Transdermal Delivery of Cargo and 
       Methods Thereof

<130>  N12-186PCT

<140>  PCT/US12/60072
<141>  2012-10-12

<150>  US 61/547,402
<151>  2011-10-14

<150>  US 61/578,463
<151>  2011-12-21

<150>  US 61/577,410
<151>  2011-12-19

<160>  20    

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  MET Receptor Binding Peptide

<400>  1

Ala Ser Val His Phe Pro Pro 
1               5           


<210>  2
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  MET Receptor Binding Peptide

<400>  2

Thr Ala Thr Phe Trp Phe Gln 
1               5           


<210>  3
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  MET Receptor Binding Peptide

<400>  3

Thr Ser Pro Val Ala Leu Leu 
1               5           


<210>  4
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  MET Receptor Binding Peptide

<400>  4

Ile Pro Leu Lys Val His Pro 
1               5           


<210>  5
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  MET Receptor Binding Peptide

<400>  5

Trp Pro Arg Leu Thr Asn Met 
1               5           


<210>  6
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  Free SP94 peptide

<400>  6

Ser Phe Ser Ile Ile Leu Thr Pro Ile Leu Pro Leu 
1               5                   10          


<210>  7
<211>  15
<212>  PRT
<213>  artificial sequence

<220>
<223>  Cys-SP94 peptide

<400>  7

Ser Phe Ser Ile Ile Leu Thr Pro Ile Leu Pro Leu Gly Gly Cys 
1               5                   10                  15  


<210>  8
<211>  18
<212>  PRT
<213>  artificial sequence

<220>
<223>  SP94 peptide

<400>  8

Ser Phe Ser Ile Ile Leu Thr Pro Ile Leu Pro Leu Glu Glu Glu Gly 
1               5                   10                  15      


Gly Cys 
        


<210>  9
<211>  42
<212>  PRT
<213>  artificial sequence

<220>
<223>  Nuclear localization peptides

<400>  9

Gly Asn Gln Ser Ser Asn Phe Gly Pro Met Lys Gly Gly Asn Phe Gly 
1               5                   10                  15      


Gly Arg Ser Ser Gly Pro Tyr Gly Gly Gly Gly Gln Tyr Phe Ala Lys 
            20                  25                  30          


Pro Arg Asn Gln Gly Gly Tyr Gly Gly Cys 
        35                  40          


<210>  10
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  Nuclear localization peptides

<400>  10

Arg Arg Met Lys Trp Lys Lys 
1               5           


<210>  11
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  Nuclear localization peptides

<400>  11

Pro Lys Lys Lys Arg Lys Val 
1               5           


<210>  12
<211>  16
<212>  PRT
<213>  artificial sequence

<220>
<223>  Nuclear localization peptides

<400>  12

Lys Arg Pro Ala Ala Thr Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys 
1               5                   10                  15      


<210>  13
<211>  25
<212>  PRT
<213>  artificial sequence

<220>
<223>  H5WYG fusogenic peptide

<400>  13

Gly Leu Phe His Ala Ile Ala His Phe Ile His Gly Gly Trp His Gly 
1               5                   10                  15      


Leu Ile His Gly Trp Tyr Gly Gly Cys 
            20                  25  


<210>  14
<211>  8
<212>  PRT
<213>  artificial sequence

<220>
<223>  Fusogenic peptide - polyargiine 8-mer

<400>  14

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  15
<211>  12
<212>  PRT
<213>  artificial sequence

<220>
<223>  MET Receptor Binding Peptide 12-mer

<400>  15

Tyr Leu Phe Ser Val His Trp Pro Pro Leu Lys Ala 
1               5                   10          


<210>  16
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  target un-related peptide

<400>  16

His Ala Ile Tyr Pro Arg His 
1               5           


<210>  17
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  irrelevant phage clone

<400>  17

Thr Pro Asp Trp Leu Phe Pro 
1               5           


<210>  18
<211>  7
<212>  PRT
<213>  artificial sequence

<220>
<223>  primary receptor for NiV entry via macropinocytosis

<400>  18

Thr Gly Ala Ile Leu His Pro 
1               5           


<210>  19
<211>  64
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Cyclin B1-specific siRNA  precursor DNA

<400>  19
ggatccgaaa tgtaccctcc agaaattgaa ttcgtttctg gagggtacat ttctttttga       60

attc                                                                    64


<210>  20
<211>  21
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Cyclin B1-specific siRNA

<400>  20
gaaauguacc cuccagaaau u                                                 21


